MedTrace Logo

HFNC for Postoperative Atelectasis After Laparoscopic Surgery

NCT07676760 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2026-06-30

No results posted yet for this study

Summary

Pneumoperitoneum and Trendelenburg positioning during laparoscopic surgery promote atelectasis development, which has been reported in up to 90% of patients under general anesthesia and increases the risk of postoperative pulmonary complications. High-flow nasal cannula (HFNC) oxygen therapy may reduce post-extubation atelectasis through alveolar recruitment. This prospective observational cohort study aims to evaluate the role of HFNC in postoperative atelectasis monitored by lung ultrasonography (LUS) in patients undergoing elective laparoscopic surgery.

Conditions

  • Postoperative Atelectasis
  • Postoperative Pulmonary Complications

Interventions

OTHER

High-Flow Nasal Cannula (HFNC)

HFNC Group

OTHER

Conventional Oxygen Therapy

Standard oxygen therapy administered via face mask or nasal cannula after extubation following elective laparoscopic surgery.

Sponsors & Collaborators

  • Bursa Yuksek Ihtisas Training and Research Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2027-07-31
Completion
2027-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07676760 on ClinicalTrials.gov